Suchergebnisse - "Hoskin, Peter"

1

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

von: Hoskin, Peter

2021, in: My

Wird geladen...
2

Double the Target Volumes

von: Hoskin, Peter

2020, in: International journal of radiation oncology, biology, physics

Wird geladen...
3

High-dose-rate brachytherapy with two or three fractions as monotherapy in the treatment of locally advanced prostate cancer

von: Hoskin, Peter

2014, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
4

Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer

von: Hoskin, Peter

2017, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
5

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

von: Hoskin, Peter

2014, in: My

Wird geladen...
6

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres

von: Hoskin, Peter

2024, in: BMC cancer

Wird geladen...
7

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

von: Hoskin, Peter

2014, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
8

IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases

von: Hoskin, Peter

2015, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
9

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update

von: Hoskin, Peter J.

2013transfer abstract, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
10

Treat All Known Disease

von: Hoskin, Peter J.

2017, in: Xiaokeping-induced autophagy protects pancreatic β-cells against apoptosis under high glucose stress

Wird geladen...
11

Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results

von: Hoskin, Peter J.

2021, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
12

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial

von: Hoskin, Peter J

2014, in: My

Wird geladen...
13

Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy

von: Hoskin, Peter J.

2014, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...
14

Single Fraction High-Dose-Rate Brachytherapy: Too Good to Be True?

von: Morton, Gerard C.

2019, in: Xiaokeping-induced autophagy protects pancreatic β-cells against apoptosis under high glucose stress

Wird geladen...
15

Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial

von: Hoskin, Peter J.

2022, in: Radiotherapy and oncology

Wird geladen...
16

Introduction

von: Hoskin, Peter J.

2003, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
17

Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses

von: Fischer, Andrea M.

2022, in: Radiation oncology

Wird geladen...
18

Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues

von: Choudhury, Ananya

2019, in: Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise

Wird geladen...
19

Reply to Thomas Seisen, Morgan Rouprêt, Quoc-Dien Trinh, and Joaquim Bellmunt’s Letter to the Editor re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol 2023;41:4406–15

von: Swinton, Martin

2023, in: European urology

Wird geladen...
20

Overall response rates to radiation therapy for patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment

von: Bedard, Gillian

2014, in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells

Wird geladen...

1
2
3
4
5
6
7
Nächster
[7]

Nicht das Richtige dabei?

Schreiben Sie uns!